Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 483-492, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hackler, R.
Right arrow Articles by Schaefer, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hackler, R.
Right arrow Articles by Schaefer, J. R.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:483-492.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Investigation by Isoelectric Focusing of the Initial Carbohydrate-deficient Transferrin (CDT) and non-CDT Transferrin Isoform Fractionation Step Involved in Determination of CDT by the ChronAlcoI.D. Assay

Rolf Hackler1, Torsten Arndt2,a, Angelika Helwig-Rolig3, Juergen Kropf3, Armin Steinmetz4 and Juergen R. Schaefer1

1 Zentrum für Innere Medizin, Abteilung Kardiologie, Baldingerstrasse, Philipps-Universität, D-35033 Marburg, Germany.

2 bioscientia, Institut für Laboruntersuchungen Ingelheim GmbH, Konrad-Adenauer-Strasse 17, D-55218 Ingelheim, Germany.

3 Abteilung Klinische Chemie und Pathobiochemie-Zentrallaboratorium, Baldingerstrasse, Philipps-Universität, D-35033 Marburg, Germany.

4 Abteilung Innere Medizin und Zentrallabor, St. Nikolaus-Stiftshospital, D-56626 Andernach, Germany.
a Author for correspondence. Fax 049-6132-781-428; e-mail arndt{at}bioscientia.de

Background: The introduction of a new set of reagents for the determination of carbohydrate-deficient transferrin (CDT) as a marker of chronic alcohol abuse requires an independent evaluation of the analytic specificity of the test. This information is needed for correct interpretation and classification of test results.

Methods: Isoelectric focusing on the PhastSystemTM followed by immunofixation, silver staining, and densitometry was used to validate the initial transferrin isoform fractionation step on anion-exchange microcolumns involved in the ChronAlcoI.D.TM assay.

Results: The in vitro transferrin iron load was complete and stable. The CDT and non-CDT transferrin fractionation on anion-exchange microcolumns was reliable and reproducible (CV <=10%). Except for quantitatively unimportant traces of trisialo-Fe2-transferrin (<5% of total CDT), only asialo-, mono-, and disialo-Fe2-transferrin were detected in the microcolumn eluates (n = 170). There was a loss of proportionally similar amounts of asialo-Fe2-transferrin (during column rinsing) and disialo-Fe2-transferrin (on the anion exchanger). Thus, the peak height ratios for disialo- and asialo-Fe2-transferrin did not change from >1 (serum) to <1 (eluates) as described for the CDTect assays. The transferrin patterns in the ChronAlcoI.D. eluates were representative of those in serum. Transferrin D variants with isoelectric points close to that of trisialo-Fe2-transferrin C1 did not cause overdetermination of CDT by the ChronAlcoI.D. test.

Conclusions: The initial CDT and non-CDT fractionation step involved in determination of CDT by the ChronAlcoI.D. assay is efficient for eliminating non-CDT transferrins from serum before quantification of CDT in the final turbidimetric immunoassay. We recommend IEF for validation of other (commercial) CDT analysis methods and of odd CDT results.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
T. Arndt
Asialotransferrin--An Alternative to Carbohydrate-deficient Transferrin?
Clin. Chem., June 1, 2003; 49(6): 1022 - 1023.
[Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
M. J. Schwarz, I. Domke, A. Helander, P. M. W. Janssens, J. van Pelt, B. Springer, M. Ackenheil, K. Bernhardt, G. Weigl, and M. Soyka
MULTICENTRE EVALUATION OF A NEW ASSAY FOR DETERMINATION OF CARBOHYDRATE-DEFICIENT TRANSFERRIN
Alcohol Alcohol., May 1, 2003; 38(3): 270 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry
Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption
Clin. Chem., March 1, 2003; 49(3): 440 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. de Loos, K. M.L.C. Huijben, N. C.A.J. van der Kar, L. A.H. Monnens, L. P.W.J. van den Heuvel, J. E.M. Groener, R. A. de Moor, and R. A. Wevers
Hemolytic Uremic Syndrome Attributable to Streptococcus pneumoniae Infection: A Novel Cause for Secondary Protein N-Glycan Abnormalities
Clin. Chem., May 1, 2002; 48(5): 781 - 784.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Helander, G. Eriksson, H. Stibler, and J.-O. Jeppsson
Interference of Transferrin Isoform Types with Carbohydrate-deficient Transferrin Quantification in the Identification of Alcohol Abuse
Clin. Chem., July 1, 2001; 47(7): 1225 - 1233.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Arndt
Carbohydrate-deficient Transferrin as a Marker of Chronic Alcohol Abuse: A Critical Review of Preanalysis, Analysis, and Interpretation
Clin. Chem., January 1, 2001; 47(1): 13 - 27.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.